Tanaka, F., Yanagihara, K., Ohtake, Y., Miyahara, R., Kawano, Y., Fukuse, T., . . . Wada, H. (1999). p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non‐small Cell Lung Cancer. Jpn J Cancer Res.
Citación estilo ChicagoTanaka, Fumihiro, Kazuhiro Yanagihara, Yohsuke Ohtake, Ryou Miyahara, Youzou Kawano, Tatsuo Fukuse, Shigeki Hitomi, y Hiromi Wada. "P53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non‐small Cell Lung Cancer." Jpn J Cancer Res 1999.
Cita MLATanaka, Fumihiro, et al. "P53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non‐small Cell Lung Cancer." Jpn J Cancer Res 1999.